Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Supplement Market Regulation: Depression Claim, Undisclosed Drug, COVID Tincture

Feb 19 2021

• By Malcolm Spicer

Related Content

Amazon’s VMS Policy Mirrors US FDA Rules But May Reflect Stronger Industry Compliance

Jan 12 2021

Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements

Jan 12 2021

Despite FDA Request, Consumer Alert, Firm Won't Recall Spiked Supplement

Jan 29 2020

Next US FDA Commissioner Will Have Opening To Fill In Dietary Supplement Programs Office

Feb 18 2021

Another 'Rhino' Marketer Horned By US FDA About ED-Spiked Supplements

Apr 24 2019

Additional Topics

United States US States Dietary Supplements Enforcement FDA Advertising, Marketing & Sales Commercial Companies Coronavirus COVID-19 Distribution E-Commerce Ingredients Manufacturing Policy Recalls Regulation Retail Consumer

More from Compliance

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window